Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Ototoxicity × 1 year × Clear all

Status

Sponsor Class

OTHER 8 OTHER_GOV 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 64 Neoplasms 44 Uterine Cervical Neoplasms 28 Colorectal Neoplasms 21 Stomach Neoplasms 17 Carcinoma, Non-Small-Cell Lung 17 Lung Neoplasms 16 Prostatic Neoplasms 14 Carcinoma, Hepatocellular 14 Ovarian Neoplasms 13 Esophageal Neoplasms 12 Pancreatic Neoplasms 11 Multiple Myeloma 10 Urinary Bladder Neoplasms 9 Recurrence 9 Brain Neoplasms 9 Endometrial Neoplasms 8 Motor Activity 7 Melanoma 7 Lymphoma 7 Hematologic Neoplasms 7 Gastrointestinal Neoplasms 7 Rectal Neoplasms 6 Pain, Postoperative 6 Leukemia 6 Depression 6 Colonic Neoplasms 6 Triple Negative Breast Neoplasms 5 Sleep Initiation and Maintenance Disorders 5 Sarcopenia 5

Interventions

Radiotherapy 1 Drug Therapy 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06551857 2025-04-16

CaSPiN

Turku University Hospital

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡